Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of chronic and genetic diseases
3.2.1.2 Technological advancement in cell therapy
3.2.1.3 Increasing investment in research & development activities
3.2.2 Industry pitfalls & challenges
3.2.2.1 Regulatory challenges
3.2.2.2 Complexity of cell therapy development
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Service, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Clinical trial design & planning
5.3 Supply & logistics services
5.4 Regulatory affairs & compliance
5.5 Data management & biostatistics
5.6 Site management & monitoring
5.7 Other services
Chapter 6 Market Estimates and Forecast, By Phase, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Phase I
6.3 Phase II
6.4 Phase III
6.5 Phase IV
Chapter 7 Market Estimates and Forecast, By Indication, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Oncology
7.3 Hematology
7.4 Neurology
7.5 Cardiovascular diseases
7.6 Musculoskeletal disorders
7.7 Other indications
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical & biotechnology companies
8.3 Contract research organizations
8.4 Academic & research institutes
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 ICON PLC
10.2 IQVIA
10.3 Medpace, Inc.
10.4 Laboratory Corporation of America Holdings
10.5 Parexel International
10.6 Worldwide Clinical Trials
10.7 Charles River Laboratories International, Inc.
10.8 Syneos Health
10.9 Thermo Fisher Scientific Inc.
10.10 Novotech
10.11 Catalent Pharma
10.12 Precision Medicine Group, LLC
Cell Therapy Clinical Trial Services Market Analysis
Download Free Sample
Based on the service, the global market is classified into clinical trial design and planning, supply & logistics services, regulatory affairs & compliance, data management & biostatics, site management & monitoring, and other services. The regulatory affairs & compliance segment dominated the market with revenue of USD 662.4 million in 2023.
Download Free Sample
Based on the phase, the global cell therapy clinical trial services market is classified into phase I, phase II, phase III, and phase IV. The phase II segment dominated the market with market share of 35.2% in 2023.
Based on the indication, the global cell therapy clinical trial services market is classified into oncology, hematology, neurology, cardiovascular diseases, musculoskeletal disorders, and other indications. The oncology segment is expected to reach USD 2.8 billion by end of 2032.
Based on end-use, the cell therapy clinical trial services market is classified into pharmaceutical & biotechnology companies, contract research organizations, academic & research institutes, and other end-users. The pharmaceutical & biotechnology companies’ segment is expected to exhibit 10.9% CAGR between 2024 - 2032.
Download Free Sample
In 2023, North America secured a substantial market share of 43.2% in the global cell therapy clinical trial services market and is expected to dominate throughout the forecast period.
Germany to experience the highest growth rate in the market, outstripping other countries in Europe in the assessment period.
The Asia Pacific cell therapy clinical trial services market is expected to grow with a significant CAGR during the forecast period.
Cloud-native Application Protection Platform Market
Deck Software Market
Wealth Management Platform Market
Progressive Web App Market